Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Evaluation of the anticancer efficacy of a new chimeric antigen receptor targeting PD-L1 molecule

2016/23/B/NZ6/02535

Keywords:

cancer chimeric antigen receptor CAR immune checkpoint PD-L1 adoptive therapy T lymphocytes NK cells synNotch strategy

Descriptors:

  • NZ5_7: Human disease treatment
  • NZ6_1: Adaptive and innate immunity
  • NZ3_7: Signal transduction

Panel:

NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution :

Warszawski Uniwersytet Medyczny, Wydział Lekarski

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Radosław Zagożdżon 

Number of co-investigators in the project: 4

Call: OPUS 12 - announced on 2016-09-15

Amount awarded: 1 688 480 PLN

Project start date (Y-m-d): 2017-07-10

Project end date (Y-m-d): 2021-01-09

Project duration:: 42 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Cytometr FACSLyric wyposażony w trzy lasery (niebieski, czerwony,fioletowy), umożliwiający jednoczesny pomiar 8 fluorescencji (4/2/2) + FSC/SSC.
  2. Laser 561-nm do cytometru przepływowego (350 000 PLN)

Information in the final report

  • Publication in academic press/journals (2)
  1. Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
    Authors:
    Katsiaryna Marhelava, Zofia Pilch, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Radoslaw Zagozdzon
    Academic press:
    Cancers (rok: 2019, tom: 11, strony: 1756), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers11111756 - link to the publication
  2. PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
    Authors:
    Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Katsiaryna Marhelava, Anna Burdzinska, Angelika Muchowicz, Agnieszka Goral, Andriy Zhylko, Karolina Soroczynska, Kuba Retecki, Marta Krawczyk, Marta Klopotowska, Zofia Pilch, Leszek Paczek, Karl-Johan Malmberg, Sébastien Wälchli, Magdalena Winiarska,Radoslaw Zagozdzon
    Academic press:
    Journal for ImmunoTherapy of Cancer , Wydawca: British Medical Journal / Society for Immunotherapy of Cancer
    Status:
    Accepted for publication